The deal was held up in court amid Daiichi Sankyo's long-running dispute with the Singh brothers over its purchase of Ranbaxy Laboratories more than a decade ago
Senior advocate Arvind Nigam, appearing for Daiichi, said this was a deliberate attempt to deprive the company from enjoying the fruits of the award in its favour
The court also directed the brothers and 12 others, including their family members and companies, to come up with a plan on how they seek to deposit the amount of Rs 3.5 billion